Literature DB >> 27688835

Innovation Tops Current Trends in the 2016 Oncology Drug Pipeline.

Dalia Buffery1.   

Abstract

Year:  2016        PMID： 27688835      PMCID： PMC5004820     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN： 1942-2962


× No keyword cloud information.
  2 in total

Review 1.  Trends in Biotechnological Drugs for Cancer Treatment.

Authors:  Natalia L von Ranke; Iolanda M Fierro; Adelaide M S Antunes
Journal:  Recent Pat Anticancer Drug Discov       Date:  2016       Impact factor: 4.169

2.  NCCN Evidence Blocks.

Authors:  Robert W Carlson; Eric Jonasch
Journal:  J Natl Compr Canc Netw       Date:  2016-05       Impact factor: 11.908
  2 in total
  4 in total

Review 1.  A Concept Analysis of Oral Anticancer Agent Self-management.

Authors:  Madilyn Mason; Marcelline R Harris; Joseph A Greer; Yun Jiang
Journal:  Cancer Nurs       Date:  2022 Mar-Apr 01       Impact factor: 2.592

Review 2.  The Anticancer Drug Discovery Potential of Marine Invertebrates from Russian Pacific.

Authors:  Vladimir L Katanaev; Salvatore Di Falco; Yuri Khotimchenko
Journal:  Mar Drugs       Date:  2019-08-16       Impact factor: 5.118

3.  Factors Affecting Usage Levels and Trends of Innovative Oncology Drugs Upon and After Reimbursement Under Taiwan National Health Insurance: Interrupted Time Series Analysis.

Authors:  Kai-Hsin Liao; Bor-Sheng Ko; Liang-Kung Chen; Fei-Yuan Hsiao
Journal:  Clin Transl Sci       Date:  2020-07-16       Impact factor: 4.689

4.  A validation of clinical data captured from a novel Cancer Care Quality Program directly integrated with administrative claims data.

Authors:  David M Kern; John J Barron; Bingcao Wu; Alex Ganetsky; Vincent J Willey; Ralph A Quimbo; Michael J Fisch; Joseph Singer; Ann Nguyen; Ronac Mamtani
Journal:  Pragmat Obs Res       Date:  2017-08-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.